Cimzia (Certolizumab Pegol)
Cimzia is a medicine called a Tumor Necrosis Factor (TNF) blocker. Cimzia is a medicine used in adults to lessen the signs and symptoms of moderately to severely active Crohn’s disease after usual treatments did not help. It is also used to treat moderately to severely active rheumatoid arthritis.
Cimzia is a medicine that affects your immune system. Cimzia can lower the ability of the immune system to fight infections. Serious infections have happened in patients taking Cimzia. These infections include tuberculosis (TB) and infections caused by viruses, fungi or bacteria that have spread throughout the body. Some patients have died from these infections.
Your doctor will test you for TB before starting Cimzia and monitor you closely for signs and symptoms of TB during treatment with Cimzia.
Cimzia can worsen or cause congestive heart failure (a condition in which the heart cannot pump enough blood throughout the body). Symptoms include shortness of breath, swelling of your ankles or feet, or sudden weight gain. Call your doctor immediately if these symptoms develop.
Cimzia can cause allergic reactions. Signs include a skin rash, trouble breathing, or swelling of the face, tongue, lips, or throat. Call your doctor immediately if these symptoms develop.
Cimzia can cause serious nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes. Symptoms include dizziness, numbness or tingling, problems with your vision, and weakness in your arms or legs. Call your doctor if any of these symptoms develop.
Cimzia can increase the risk of developing lymphoma (a type of cancer involving cells of the immune system called lymphocytes) or other types of cancer. Contact your doctor immediately if you develop unusual lumps or swelling in your neck, armpit, or groin, night sweats, recurring fever, unusual tiredness or weakness, persistent unexplained itching, or unexplained weight loss.